Generation Bio PE Ratio 2020-2024 | GBIO
Current and historical p/e ratio for Generation Bio (GBIO) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Generation Bio PE ratio as of May 14, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Generation Bio PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-05-15 |
3.79 |
|
0.00 |
| 2024-03-31 |
4.07 |
$-1.43 |
0.00 |
| 2023-12-31 |
1.65 |
$-1.96 |
0.00 |
| 2023-09-30 |
3.79 |
$-1.98 |
0.00 |
| 2023-06-30 |
5.50 |
$-2.08 |
0.00 |
| 2023-03-31 |
4.30 |
$-2.27 |
0.00 |
| 2022-12-31 |
3.93 |
$-2.35 |
0.00 |
| 2022-09-30 |
5.31 |
$-2.34 |
0.00 |
| 2022-06-30 |
6.56 |
$-2.37 |
0.00 |
| 2022-03-31 |
7.34 |
$-2.26 |
0.00 |
| 2021-12-31 |
7.08 |
$-2.11 |
0.00 |
| 2021-09-30 |
25.07 |
$-2.10 |
0.00 |
| 2021-06-30 |
26.90 |
$-2.00 |
0.00 |
| 2021-03-31 |
28.46 |
$-2.95 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.236B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
